Eli Lilly and Company (LLY)
NYSE · Healthcare
Eli Lilly and Company Shareholder Equity 2020–2025
Eli Lilly and Company annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Eli Lilly and Company shareholder equity as of December 31, 2025: 26.54B, a 85.93% increase year-over-year.
- Eli Lilly and Company shareholder equity for 2025 were 26.54B, a 85.93% increase from 2024.
- Eli Lilly and Company shareholder equity for 2024 were 14.27B, a 31.37% increase from 2023.
- Eli Lilly and Company shareholder equity for 2023 were 10.86B, a 0.82% increase from 2022.
- Eli Lilly and Company shareholder equity for 2022 were 10.78B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Eli Lilly and Company Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $26,535 |
| 2024 | $14,272 |
| 2023 | $10,864 |
| 2022 | $10,775 |
| 2021 | $9,155 |
| 2020 | $5,825 |
Eli Lilly and Company Shareholder Equity — FAQ
Eli Lilly and Company (LLY) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LLY's shareholder equity history?
The chart and table above show Eli Lilly and Company's shareholder equity by year and by quarter, including the growth rate.